PubMed:19749203 / 251-369
Annnotations
Inflammaging
{"project":"Inflammaging","denotations":[{"id":"T3","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":118},"obj":"Sentence"}],"text":"Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":118},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc."}
GlycoBiology-FMA
{"project":"GlycoBiology-FMA","denotations":[{"id":"_T5","span":{"begin":73,"end":78},"obj":"FMAID:196724"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc."}
GlyTouCan-IUPAC
{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T1","span":{"begin":73,"end":78},"obj":"\"http://rdf.glycoinfo.org/glycan/G59665TO\""},{"id":"GlycanIUPAC_T2","span":{"begin":73,"end":78},"obj":"\"http://rdf.glycoinfo.org/glycan/G32915EI\""},{"id":"GlycanIUPAC_T3","span":{"begin":73,"end":78},"obj":"\"http://rdf.glycoinfo.org/glycan/G60625TS\""}],"text":"Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":118},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc."}
GlyCosmos15-Sentences
{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T3","span":{"begin":0,"end":118},"obj":"Sentence"}],"text":"Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc."}